Pds biotech announces presentations in upcoming healthcare investor conferences

Florham park, n.j., march 03, 2021 (globe newswire) -- pds biotechnology corporation (nasdaq: pdsb), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the company's proprietary versamune® t-cell activating technology, today announced that frank bedu-addo, ceo of pds biotech, will present at the h.c. wainwright global life sciences conference being held from march 9-10, and at the 31st annual oppenheimer healthcare conference being held from march 16-18. both conferences are being hosted virtually.
PDSB Ratings Summary
PDSB Quant Ranking